Analyse

Fundierte Analysen zu Pharmamärkten, Lieferketten, Technologie und Regulierung

#pharmacy platform ×

21. Sept. 2026•1 Min. Lesezeit

BaroPharm Submits Securities Filing, Begins KOSDAQ IPO Process

BaroPharm filed a securities report with the Financial Services Commission and announced a public offering of 1.78 million shares, targeting a 16,400‑22,200 KRW price range, aiming for a KOSDAQ listing this year.